Opko Health, Inc. (OPK) holds a unique position within the healthcare sector, particularly in the diagnostics and research industry. With its headquarters in Miami, Florida, Opko Health operates a diverse..
Ocular Therapeutix, Inc. (NASDAQ: OCUL), a key player in the biotechnology sector, is capturing investor attention with its innovative approach in treating retinal diseases and other eye conditions. Despite recent..
Investors with an eye on the biotechnology sector may want to consider Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage company specializing in novel therapeutics for rare endocrine diseases. With a..
Investors in BGM Group Ltd. (BGM) might be intrigued by its unique position within the healthcare sector, specifically the drug manufacturers – specialty & generic industry in China. With a..
Artivion, Inc. (NYSE: AORT) stands out in the healthcare sector with its innovative medical devices and implantable human tissues. Headquartered in Kennesaw, Georgia, Artivion, formerly known as CryoLife, Inc., offers..
Evotec SE (EVO), a prominent player in the healthcare sector, specializes in drug discovery and development with operations spanning across the globe. Based in Hamburg, Germany, Evotec SE is classified..
Merus N.V. (MRUS), a prominent player in the biotechnology industry, offers an intriguing opportunity for investors seeking to navigate the complex landscape of healthcare innovation. Headquartered in Utrecht, Netherlands, Merus..
MiMedx Group, Inc. (NASDAQ: MDXG), a prominent player in the biotechnology sector, is currently capturing investor attention with a potential upside of 76.56%, as indicated by its average target price...
Ardent Health, Inc. (NYSE: ARDT) presents a compelling opportunity for investors seeking value in the healthcare sector, with a standout potential upside of 52.53%. Based in Brentwood, Tennessee, Ardent Health..
Premier, Inc. (NASDAQ: PINC), a key player in the health information services sector, continues to navigate the complexities of the U.S. healthcare industry with a focus on optimizing supply chains..
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a prominent player in the biotechnology sector, is making waves with its strategic focus on rare diseases. Headquartered in Coral Gables, Florida, this commercial-stage biopharmaceutical..
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a trailblazer in the biopharmaceutical sector, is making waves in the healthcare industry with its cutting-edge therapeutic developments. Headquartered in Irvine, California, Tarsus is focused..
Healthcare Services Group, Inc. (HCSG), a prominent player in the healthcare sector, is making waves with its significant presence in medical care facilities across the United States. With a current..
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a dynamic player in the biotechnology sector, has been capturing investor attention with its promising developments in the treatment of serious and rare diseases. Based..
Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical leader in the healthcare sector, is catching the attention of investors with its robust revenue growth and favorable analyst ratings. Based in San..
Denali Therapeutics Inc. (NASDAQ: DNLI) is capturing the attention of investors within the biotechnology sector, thanks to a remarkable potential upside of 94.30% as indicated by analyst ratings. With a..
Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology sector, is making waves with its innovative therapeutic antibodies aimed at addressing severe inflammatory, allergic, autoimmune, and other diseases...
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands out in the biotechnology sector with its impressive growth metrics and a robust pipeline of biopharmaceutical assets. Based in Jupiter, Florida, Ligand specializes in..
Investors eyeing the healthcare sector might want to give ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) a closer look. This biopharmaceutical company, headquartered in Baudette, Minnesota, is making waves in the drug..
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands as a compelling focus for investors interested in the biotechnology sector. With its current market cap at $1.9 billion and a strong emphasis on..
